ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Neurology Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MUHAMMAD KAREEM MD

Neurology

5,166

$631K

554
315 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$122
Average prescription price

Avg: $236

GEORGIA MONTOURIS M.D.

Neurology

5,165

$1.25M

313
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 24%

$242
Average prescription price

Avg: $236

ROBERT POWELL D.O.

Neurology

4,594

$578K

176
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 24%

$126
Average prescription price

Avg: $236

ALBERT ACKIL M.D.

Neurology

4,172

$555K

497
283 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

2%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$133
Average prescription price

Avg: $236

JAMES GILBERT MD

Neurology

4,040

$810K

356
202 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$201
Average prescription price

Avg: $236

CATHERINE PHILLIPS M.D.

Neurology

4,012

$453K

245
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$113
Average prescription price

Avg: $236

JONATHAN MORAY M.D.

Neurology

3,673

$904K

346
175 are 65+

12%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$246
Average prescription price

Avg: $236

JAMES MCCARTHY MD

Neurology

3,530

$468K

389
198 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 24%

$133
Average prescription price

Avg: $236

JONATHAN MARTIN M.D.

Neurology

3,511

$2.04M

217
67 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$581
Average prescription price

Avg: $236

EMILIO MELCHIONNA M.D.

Neurology

3,494

$1.11M

482
260 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$317
Average prescription price

Avg: $236

MOHAMMAD HAZRATJI MD

Neurology

3,488

$502K

431
230 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 24%

$144
Average prescription price

Avg: $236

PAULA RAVIN M.D.

Neurology

3,357

$611K

226
141 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$182
Average prescription price

Avg: $236

PAUL BLACHMAN MD

Neurology

3,194

$624K

434
328 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$195
Average prescription price

Avg: $236

MICHAEL LEAHY M.D.

Neurology

3,179

$435K

273
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$137
Average prescription price

Avg: $236

JOHN STAMOULIS MD

Neurology

3,106

$617K

366
211 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$199
Average prescription price

Avg: $236

MIKHAIL VYDRIN M.D.

Neurology

3,104

$582K

290
130 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 24%

$188
Average prescription price

Avg: $236

BONNIE HERSH MD

Neurology

2,886

$750K

248
202 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 24%

$260
Average prescription price

Avg: $236

GARY KEILSON MD

Neurology

2,755

$436K

355
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$158
Average prescription price

Avg: $236

THEODORE GAVRILESCU MD

Neurology

2,735

$490K

257
160 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$179
Average prescription price

Avg: $236

MARK GIBSON MD

Neurology

2,695

$508K

287
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$189
Average prescription price

Avg: $236

LISA FERLEY MD

Neurology

2,677

$505K

283
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$189
Average prescription price

Avg: $236

RANBIR DHILLON M.D.

Neurology

2,606

$943K

226
115 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$362
Average prescription price

Avg: $236

AUBREY LIEBERMAN MD

Neurology

2,597

$430K

220
131 are 65+

18%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$165
Average prescription price

Avg: $236

WILLIAM TOSCHES MD

Neurology

2,507

$595K

204
108 are 65+

12%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$237
Average prescription price

Avg: $236

SHABBIR ABBASI M.D.

Neurology

2,471

$332K

359
260 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$134
Average prescription price

Avg: $236

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank